GASTROINTESTINAL AND ABDOMINAL RADIOLOGY / ORIGINAL PAPER
Is hepatosteatosis overlooked in ultrasound relying only on B-mode? The impact of incorporating the attenuation coefficient into
the standard abdominal ultrasound protocol
1
Department of Diagnostic Imaging, Provincial Specialist Hospital No. 5 St. Barbara’s in Sosnowiec, Poland
2
Department of Radiology and Nuclear Medicine, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
3
Collegium Medicum, Jan Dlugosz University in Czestochowa, Poland
4
Collegium Medicum, WSB University, Dabrowa Gornicza, Poland
These authors had equal contribution to this work
Submission date: 2025-03-30
Final revision date: 2025-05-27
Acceptance date: 2025-06-02
Publication date: 2025-08-27
Corresponding author
Maciej Cebula
Department of Diagnostic Imaging, Provincial Specialist Hospital No. 5 St. Barbara’s in Sosnowiec, 14 Medyków St., 41-214 Sosnowiec, Poland
Department of Diagnostic Imaging, Provincial Specialist Hospital No. 5 St. Barbara’s in Sosnowiec, 14 Medyków St., 41-214 Sosnowiec, Poland
Pol J Radiol, 2025; 90: 431-437
KEYWORDS
ultrasonographyliver steatosisattenuation coefficientmetabolic dysfunction-associated steatotic liver diseasequantitative ultrasound
TOPICS
ABSTRACT
Purpose:
Metabolic dysfunction-associated steatotic liver disease is currently one of the most common forms of chronic liver disease. This study aimed to assess whether extending the standard abdominal ultrasound protocol with quantitative liver evaluation increased the number of detected cases of liver steatosis.
Material and methods:
This study was a retrospective cross-sectional comparison of the detectability of liver steatosis in a study group of 108 patients analysed using the attenuation coefficient, in relation to a matched control group assessed qualitatively with B-mode.
Results:
Quantitative assessment based on the attenuation coefficient detected more patients with liver steatosis than qualitative assessment based on B-mode. With visual assessment in B-mode, we missed a significant number of patients, mainly those with an S1 steatosis grade.
Conclusions:
The inclusion of quantitative liver evaluation in everyday practice seems justified, despite current problems with selecting the optimal assessment method and the lack of population-specific cut-off values.
Metabolic dysfunction-associated steatotic liver disease is currently one of the most common forms of chronic liver disease. This study aimed to assess whether extending the standard abdominal ultrasound protocol with quantitative liver evaluation increased the number of detected cases of liver steatosis.
Material and methods:
This study was a retrospective cross-sectional comparison of the detectability of liver steatosis in a study group of 108 patients analysed using the attenuation coefficient, in relation to a matched control group assessed qualitatively with B-mode.
Results:
Quantitative assessment based on the attenuation coefficient detected more patients with liver steatosis than qualitative assessment based on B-mode. With visual assessment in B-mode, we missed a significant number of patients, mainly those with an S1 steatosis grade.
Conclusions:
The inclusion of quantitative liver evaluation in everyday practice seems justified, despite current problems with selecting the optimal assessment method and the lack of population-specific cut-off values.
REFERENCES (37)
1.
Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, et al. 2019 Global NAFLD prevalence: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2022; 20: 2809-2817.
2.
Huh Y, Yoon JC, Ga EN. Recent epidemiology and risk factors of nonalcoholic fatty liver disease. J Obes Metab Syndr 2022; 31: 17-27.
3.
Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology 2017; 65: 1557-1565.
4.
Younossi ZM, Harring M, Younossi Y, Ong JP, Alqahtani SA, Stepanova M. The impact of NASH to liver transplantations with hepatocellular carcinoma in the United States. Clin Gastroenterol Hepatol 2021; 20: 2915-2917.
5.
Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 2023; 77: 1797-1835.
6.
Hosseini Shabanan S, Martins VF, Wolfson T, Weeks JT, Ceriani L, Behling C, et al. MASLD: what we have learned and where we need to go – a call to action. Radiographics 2024; 44: e240048.
7.
Simon TG, Roelstraete B, Khalili H, Hagström H, Ludvigsson JF. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut 2021; 70: 1375-1382.
8.
Ajmera V, Park CC, Caussy C, Singh S, Hernandez C, Bettencourt R, et al. Magnetic resonance imaging proton density fat fraction associates with progression of fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 2018; 155: 307-310.
9.
Dietrich CF, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L, et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version). Ultraschall Med 2017; 38: e16-e47.
10.
Strauss S, Gavish E, Gottlieb P, Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. Am J Roentgenol 2007; 189: W320-W323.
11.
Curry MP, Tam E, Schneider C, Abdelgelil N, Hassanien T, Afdhal NH. The use of Noninvasive Velacur® for discriminating between volunteers and patients with chronic liver disease: a feasibility study. Int J Hepatol 2024; 2024: 8877130.
12.
Ibrahim MN, Blázquez-García R, Lightstone A, Meng F, Bhat M, El Kaffas A, et al. Automated fatty liver disease detection in point-of-care ultrasound B-mode images. J Med Imaging 2023; 10: 034505.
13.
Ferraioli G, Barr RG, Berzigotti A, Sporea I, Wai-Sun Wong V, Reiberger T, et al. WFUMB guidelines/guidance on liver multiparametric ultrasound. Part 2: guidance on liver fat quantification. Ultrasound Med Biol 2024; 50: 1088-1098.
14.
Ferraioli G, Barr RG, Berzigotti A, Sporea I, Wai-Sun Wong V, Reiberger T, et al. WFUMB guideline/guidance on liver multiparametric ultrasound. Part 1: update to 2018 guidelines on liver ultrasound elastography. Ultrasound Med Biol 2024; 50: 1071-1087.
15.
Koizumi Y, Hirooka M, Tamaki N, Yada N, Nakashima O, Izumi N, et al. New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode. PLoS One 2019; 14: e0221548.
16.
Gbande P, Tchaou M, Makamto HDD, Dagbe M, Sonhaye L, Agoda-Koussema LK, et al. Correlation between qualitative and semi-quantitative ultrasound assessment of diffuse fatty liver disease: a case-control study. Ultrasound 2024; 32: 253-259.
17.
De Rosa L, Salvati A, Martini N, Chiappino D, Cappelli S, Mancini M, et al. An ultrasound multiparametric method to quantify liver fat using magnetic resonance as standard reference. Liver Int 2024; 44: 3008-3019.
18.
Ezenwuba BN, Hynes CM. Ultrasound screening of paediatric non-alcoholic fatty liver disease (NAFLD): a critical literature review. Radiography 2024; 30: 1317-1325.
19.
Wang P, Song D, Han J, Zhang J, Chen H, Gao R, et al. Comparing three ultrasound-based techniques for diagnosing and grading hepatic steatosis in metabolic dysfunction-associated steatotic liver disease. Acad Radiol 2025; 32: 1949-1957.
20.
Ferraioli G, Raimondi A, De Silvestri A, Filice C, Barr RG. Toward acquisition protocol standardization for estimating liver fat content using ultrasound attenuation coefficient imaging. Ultrasonography 2023; 42: 446-456.
21.
Hirooka M, Ogawa S, Koizumi Y, Yoshida Y, Goto T, Yasuda S, et al. iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study. J Gastroenterol 2024; 59: 504-514.
22.
Kaylan KB, Paul S. NAFLD no more: a review of current guidelines in the diagnosis and evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD). Curr Diab Rep 2025; 25: 5.
23.
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol 2024; 81: 492-542.
24.
Williams EE, Vuppalanchi R. Role of vibration-controlled transient elastography in the evaluation and management of metabolic dysfunction-associated steatotic liver disease. Curr Hepatol Rep 2024; 23: 355-363.
25.
Loomba R, Ramji A, Hassanein T, Yoshida EM, Pang E, Schneider C, et al. Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatol Commun 2024; 8: e0402.
26.
Serra-Burriel M, Graupera I, Torán P, Thiele M, Roulot D, Wai-Sun Wong V, et al. Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six pro-spective cohorts in Europe and Asia. J Hepatol 2019; 71: 1141-1151.
27.
Vilar-Gomez E, Lou Z, Kong N, Vuppalanchi R, Imperiale TF, Chalasani N. Cost effectiveness of different strategies for detecting cirrhosis in patients with nonalcoholic fatty liver disease based on United States health care system. Clin Gastroenterol Hepatol 2020; 18: 2305-2314.
28.
Phisalprapa P, Supakankunti S, Charatcharoenwitthaya P, Apisarnthanarak P, Charoensak A, Washirasaksiri C, et al. Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients. Medicine 2017; 96: e6585.
29.
Noureddin M, Jones C, Alkhouri N, Gomez EV, Dieterich DT, Rinella ME;NASHNET. Screening for nonalcoholic fatty liver disease in persons with type 2 diabetes in the United States is cost-effective: a comprehensive cost-utility analysis. Gastroenterology 2020; 159: 1985-1987.
30.
Dag N, Igci G, Yagin FH, Hanci MS, Kutlu R. Interobserver reproducibility of ultrasound attenuation imaging technology in liver fat quantification. J Clin Ultrasound 2025; 53: 405-412.
31.
Yuri M, Nishimura T, Tada T, Yoshida M, Fujiwara A, Kawata S, et al. Diagnosis of hepatic steatosis based on ultrasound attenuation imaging is not influenced by liver fibrosis. Hepatol Res 2022; 52: 1009-1019.
32.
Harrison AP, Li B, Hsu TH, Chen CJ, Yu WT, Tai J, et al. Steatosis quantification on ultrasound images by a deep learning algorithm on patients undergoing weight changes. Diagnostics 2023; 13: 3225.
33.
Lonardo A, Nascimbeni F, Ballestri S, Fairweather DL, Win S, Than TA, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology 2019; 70: 1457-1469.
34.
Isacco L, Ennequin G, Boisseau N. Influence of the different hormonal status changes during their life on fat mass localisation in women: a narrative review. Arch Physiol Biochem 2023; 129: 1229-1234.
35.
Jeon SK, Lee JM, Joo I, Yoon JH, Lee G. Two-dimensional convolutional neural network using quantitative US for noninvasive assessment of hepatic steatosis in NAFLD. Radiology 2023; 307: e221510.
36.
Schneider ALC, Lazo M, Selvin E, Clark JM. Racial differences in nonalcoholic fatty liver disease in the US population. Obesity 2014; 22: 292-299.
37.
Rich NE, Oji S, Mufti AR, Browning JD, Parikh ND, Odewole M, et al. Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2018; 16: 198-210.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
